Discovery of antifungal secondary metabolites from an intestinal fungus Fusarium sp.
Mingkai ZhangBaosong ChenHuanqin DaiJingzu SunHong-Wei LiuJunjie HanPublished in: The Journal of antibiotics (2023)
Intestinal fungi, which are important parts of the gut microbiota, have the ability to produce specialized metabolites that significantly contribute to maintaining the balance of the gut microbiota and promoting the health of the host organism. In the present study, two new glycosides, including fusintespyrone A (1) and cerevisterolside A (4), as well as ten known compounds were isolated from the intestinal fungus Fusarium sp. LE06. The structures of the new compounds were elucidated by a combination of spectroscopic methods, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR), along with chemical reactions and calculations of NMR and ECD spectra. Compounds 1-3 showed significant growth inhibition against Aspergillus fumigatus, Fusarium oxysporum, and Verticillium dahliae with MIC values in the range of 1.56-6.25 μg ml -1 .
Keyphrases
- magnetic resonance
- mass spectrometry
- high resolution
- ms ms
- density functional theory
- solid state
- public health
- multiple sclerosis
- liquid chromatography
- palliative care
- mental health
- molecular dynamics
- candida albicans
- high throughput
- health information
- high performance liquid chromatography
- gas chromatography
- risk assessment
- computed tomography
- magnetic resonance imaging
- social media
- single cell